Cannabis dispensary

Patients often try it for the first time for pain relief. With more than 30 randomized controlled trials on the use of cannabinoids for pain, this is one of its best-documented applications. However, the results are contradictory: some studies have concluded that cannabis or cannabinoids are effective against pain cannabis dispensary ; others, that they are no better than a placebo. In any case, more and more doctors are giving their approval. Click here for more information.

The efficacy of cannabis "has yet to be proven, but the evidence is mounting," says Andrea Furlan, scientist in the Department of Medicine at the University of Toronto and co-chair of the ECHO Ontario project, which offers healthcare providers health tools for choosing the best chronic pain treatments in cannabis dispensary. She recognizes that more studies are needed, especially on a wider range of conditions. According to her, the therapeutic use of cannabis is justified to relieve pain, especially when other treatments are ineffective.

It affects the endocannabinoid system - receptors in the brain that are sensitive to appetite, pain, mood, and memory - without our really understanding the mechanism. And, in addition to its physiological effects, it also appears to have an influence on the psychological effects of pain.

“Pain is the body's alarm system, it activates the region of the brain that controls emotions,” explains Andrea Furlan. It tells you that you can't wait any longer in cannabis dispensary, that you must stop all activity to resolve the problem. In the case of chronic pain, she adds, this reaction is not helpful because the problem cannot be solved on time. Her patients tell her that cannabis helps alleviate it.

The interaction between cannabis and chemotherapy has also been the subject of numerous studies. In 1915, Cochrane - an international nonprofit that analyzes evidence for medical decision-making - found that patients taking cannabinoids during chemotherapy were three times less likely to experience nausea and five times less vomiting than those on placebo. In some patients, medical marijuana is believed to be as effective in some patients as the antiemetics traditionally prescribed for nausea.

Cochrane points out, however, that cancer patients would report more side effects with a cannabis-based medication than with conventional treatment, including a feeling of high, dizziness and drowsiness. According to Shelita Dattani, director of practice development and knowledge translation at the Canadian Pharmacists Association in cannabis dispensary, this is why medical cannabis is not doctors' first choice for nausea.

Until now, research has mainly focused on the effectiveness of marijuana on sleep disturbed by apnea, fibromyalgia or multiple sclerosis for example. It also appears to improve the duration and restorative quality of sleep; many patients report being less tired during the day.

The idea of curing glaucoma with marijuana emerged in the 1970s, when it was discovered to lower eye pressure - one of the causes of this condition - which can lead to blindness. Yet follow-up studies of the duration of this effect concluded that it was only a few hours and that it would take up to eight doses of marijuana per day for the patient to benefit from it.

Cannabis reduces the blood supply to the optic nerve, can damage it and negate the positive effects of lowering eye pressure. In addition, newer prescription drugs are effective for longer and without these side effects; doctors give them their preference.